TITLE

ROTARY DENTAL INSTRUMENTS AND THE POTENTIAL RISK OF TRANSMISSION OF INFECTION: HERPES SIMPLEX VIRUS

AUTHOR(S)
Epstein, Joel B.; Rea, Guiseppe; Sibau, Linda; Sherlock, Christopher H.
PUB. DATE
December 1993
SOURCE
Journal of the American Dental Association (JADA);Dec93, Vol. 124 Issue 12, p55
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Studies the rotary dental instruments and the potential risk of transmission of infection. Cytopathic effect of herpes simplex virus in human foreskin fibroblast culture; Dental handpieces used during the study; Risk of transmission of Human Immunodeficiency virus in dental practice.
ACCESSION #
16856773

 

Related Articles

  • Resistance of Herpes Simplex Virus Infections to Nucleoside Analogues in HIV-Infected Patients. Levin, Myron J.; Bacon, Teresa H.; Leary, Jeffry J. // Clinical Infectious Diseases;11/1/2004 Supplement, Vol. 39, pS248 

    Antiviral treatment of herpes simplex virus (HSV) infections with nucleoside analogues has been well established for >2 decades, but isolation of drug-resistant HSV from immunocompetent patients has remained infrequent (0.1%-0.7% of isolates) during this period. Even when drug-resistant HSV is...

  • A little sore. Newnham, David // Nursing Standard;11/2/2011, Vol. 26 Issue 9, p27 

    David Newnham dreads that tell-tale tingle.

  • Recent Developments in the Management of Herpes Simplex Virus Infection in HIV-Infected Persons. Bartlett, John G. // Clinical Infectious Diseases;11/1/2004 Supplement, Vol. 39, pS237 

    The article discusses recent developments in the management of herpes simplex virus infection in HIV-infected persons. Herpes simplex virus (HSV) and HIV have certain common features, including persistence, stigma, and treatment that effectively decreases viral replication but cannot achieve...

  • Herpes Simplex Virus (HSV)-Suppressive Therapy Decreases Plasma and Genital HIV-1 Levels in HSV-2/HIV-1 Coinfected Women: A Randomized, Placebo-Controlled, Cross-Over Trial. Baeten, Jared M.; Strick, Lara B.; Lucchetti, Aldo; Whittington, William L. H.; Sanchez, Jorge; Coombs, Robert W.; Magaret, Amalia; Wald, Anna; Corey, Lawrence; Celum, Connie // Journal of Infectious Diseases;12/15/2008, Vol. 198 Issue 12, p1804 

    A randomized cross-over trial of herpes simplex virus type 2 (HSV-2)-suppressive therapy (valacyclovir, 500 mg twice daily, or placebo for 8 weeks, a 2-week washout period, then the alternative therapy for 8 weeks) was conducted among 20 Peruvianwomencoinfected with HSV-2...

  • Adherence in HIV Type 1 Prevention Trials. Baeten, Jared M. // Journal of Infectious Diseases;5/1/2010, Vol. 201 Issue 9, p1279 

    The article offers information on the results of the study on the prevention trials on the adherence of HIV Type 1. It mentions that herpes simplex virus type 2 (HSV-2) is the main cause of genital herpes that infects the majority of human immunodeficiency virus type 1 (HIV-1)-infected person...

  • Symposium: Oral herpes simplex virus infection. Duckworth, R. // Journal of the Royal Society of Medicine;Feb1979, Vol. 72 Issue 2, p126 

    Information about oral herpes simplex virus (HSV) infection discussed at a symposium on the Section of Odontology held on May 23, 1977 is presented. It is stated that the transmission of Herpesvirus hominis or HSV is through direct contact and the principal sites affected are the orofacial and...

  • Herpes Simplex Virus.  // Diseases & Disorders: A Nursing Therapeutics Manual, 2nd edition;2002, p442 

    Provides information on herpes simplex virus (HSV), a form of virus that causes infections in the mouth and genital area. Types of HSV; Ways in which HSV causes infection; Clinical diagnosis and management of HSV infection.

  • Getting research into policy - Herpes simplex virus type-2 (HSV-2) treatment and HIV infection: international guidelines formulation and the case of Ghana. Burris, H.; Parkhurst, J.; Adu-Sarkodie, Y.; Mayaud, P. // Health Research Policy & Systems;Jan2011 Supplement 1, Vol. 9, p1 

    Background: Observational epidemiological and biological data indicate clear synergies between Herpes simplex virus type 2 (HSV-2) and HIV, whereby HSV-2 enhances the potential for HIV acquisition or transmission. In 2001, the World Health Organization (WHO) launched a call for...

  • Inhibition of apoptosis by primary isolates of herpes simplex virus. Jerome, K. R.; Fox, R.; Chen, Z.; Sarkar, P.; Corey, L. // Archives of Virology;Nov2001, Vol. 146 Issue 11, p2219 

    Summary. HSV-1 inhibits apoptosis of the infected cell, presumably to increase viral yield. Weaker anti-apoptotic activity was previously reported in laboratory-adapted HSV-2, but not in two low-passage clinical HSV-2 isolates, suggesting that the anti-apoptotic effect might result from...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics